初期无症状重度主动脉瓣狭窄的自然病史:单阶段荟萃分析。

IF 3.8 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Clinical Research in Cardiology Pub Date : 2025-03-01 Epub Date: 2024-07-15 DOI:10.1007/s00392-024-02465-8
Joshua Teik Ann Tan, George Shiyao He, Jolene Li Ling Chia, Gladys Qiao Xuan Tan, Yao Neng Teo, Yao Hao Teo, Nicholas L Syn, Ping Chai, Raymond C C Wong, Tiong-Cheng Yeo, William K F Kong, Kian-Keong Poh, Ching-Hui Sia
{"title":"初期无症状重度主动脉瓣狭窄的自然病史:单阶段荟萃分析。","authors":"Joshua Teik Ann Tan, George Shiyao He, Jolene Li Ling Chia, Gladys Qiao Xuan Tan, Yao Neng Teo, Yao Hao Teo, Nicholas L Syn, Ping Chai, Raymond C C Wong, Tiong-Cheng Yeo, William K F Kong, Kian-Keong Poh, Ching-Hui Sia","doi":"10.1007/s00392-024-02465-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Current guidelines on the management strategy for patients with asymptomatic severe aortic stenosis (AS) remain unclear. This uncertainty stems from the lack of data regarding the natural history of these patients. To address this gap, we performed a systematic review and meta-analysis examining the natural history of asymptomatic severe AS patients receiving conservative treatment.</p><p><strong>Methods: </strong>The PubMed, Cochrane, and Embase databases were searched from inception to 24 January 2024 using the keywords \"asymptomatic\" AND \"aortic\" AND \"stenosis\". We included studies examining patients with asymptomatic severe AS. In interventional trials, only data from conservatively managed arms were collected. A one-stage meta-analysis was conducted using individual patient data reconstructed from published Kaplan-Meier curves. Sensitivity analysis was performed for major adverse cardiovascular outcomes in patients who remained asymptomatic throughout follow-up.</p><p><strong>Results: </strong>A total of 46 studies were included (n = 9545). The median time to the development of symptoms was 1.11 years (95% CI 0.90-1.53). 49.36% (40.85-58.59) of patients who were asymptomatic had suffered a major adverse cardiovascular event by 5 years. The median event-free time for heart failure hospitalization (HFH) was 5.50 years (95% CI 5.14-5.91) with 36.34% (95% CI 33.34-39.41) of patients experiencing an HFH by year 5. By 5 years, 79.81% (95% CI 69.26-88.58) of patients developed symptoms (angina, dyspnoea, syncope and others) and 12.36% (95% CI 10.01-15.22) of patients died of cardiovascular causes. For all-cause mortality, the median survival time was 9.15 years (95% CI 8.50-9.96) with 39.43% (CI 33.41-36.40) of patients dying by 5 years. The median time to AVR was 4.77 years (95% CI 4.39-5.17), with 52.64% (95% CI 49.85-55.48) of patients requiring an AVR by 5 years.</p><p><strong>Conclusion: </strong>Our results reveal poor cardiovascular outcomes for patients with asymptomatic severe AS on conservative treatment. A significant proportion eventually requires an AVR. Further research is needed to determine if early intervention with AVR is more effective than conservative treatment.</p>","PeriodicalId":10474,"journal":{"name":"Clinical Research in Cardiology","volume":" ","pages":"350-367"},"PeriodicalIF":3.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Natural history of initially asymptomatic severe aortic stenosis: a one-stage meta-analysis.\",\"authors\":\"Joshua Teik Ann Tan, George Shiyao He, Jolene Li Ling Chia, Gladys Qiao Xuan Tan, Yao Neng Teo, Yao Hao Teo, Nicholas L Syn, Ping Chai, Raymond C C Wong, Tiong-Cheng Yeo, William K F Kong, Kian-Keong Poh, Ching-Hui Sia\",\"doi\":\"10.1007/s00392-024-02465-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Current guidelines on the management strategy for patients with asymptomatic severe aortic stenosis (AS) remain unclear. This uncertainty stems from the lack of data regarding the natural history of these patients. To address this gap, we performed a systematic review and meta-analysis examining the natural history of asymptomatic severe AS patients receiving conservative treatment.</p><p><strong>Methods: </strong>The PubMed, Cochrane, and Embase databases were searched from inception to 24 January 2024 using the keywords \\\"asymptomatic\\\" AND \\\"aortic\\\" AND \\\"stenosis\\\". We included studies examining patients with asymptomatic severe AS. In interventional trials, only data from conservatively managed arms were collected. A one-stage meta-analysis was conducted using individual patient data reconstructed from published Kaplan-Meier curves. Sensitivity analysis was performed for major adverse cardiovascular outcomes in patients who remained asymptomatic throughout follow-up.</p><p><strong>Results: </strong>A total of 46 studies were included (n = 9545). The median time to the development of symptoms was 1.11 years (95% CI 0.90-1.53). 49.36% (40.85-58.59) of patients who were asymptomatic had suffered a major adverse cardiovascular event by 5 years. The median event-free time for heart failure hospitalization (HFH) was 5.50 years (95% CI 5.14-5.91) with 36.34% (95% CI 33.34-39.41) of patients experiencing an HFH by year 5. By 5 years, 79.81% (95% CI 69.26-88.58) of patients developed symptoms (angina, dyspnoea, syncope and others) and 12.36% (95% CI 10.01-15.22) of patients died of cardiovascular causes. For all-cause mortality, the median survival time was 9.15 years (95% CI 8.50-9.96) with 39.43% (CI 33.41-36.40) of patients dying by 5 years. The median time to AVR was 4.77 years (95% CI 4.39-5.17), with 52.64% (95% CI 49.85-55.48) of patients requiring an AVR by 5 years.</p><p><strong>Conclusion: </strong>Our results reveal poor cardiovascular outcomes for patients with asymptomatic severe AS on conservative treatment. A significant proportion eventually requires an AVR. Further research is needed to determine if early intervention with AVR is more effective than conservative treatment.</p>\",\"PeriodicalId\":10474,\"journal\":{\"name\":\"Clinical Research in Cardiology\",\"volume\":\" \",\"pages\":\"350-367\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research in Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00392-024-02465-8\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research in Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00392-024-02465-8","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:目前关于无症状重度主动脉瓣狭窄(AS)患者管理策略的指南仍不明确。这种不确定性源于缺乏有关这些患者自然病史的数据。为了填补这一空白,我们对接受保守治疗的无症状重度主动脉瓣狭窄患者的自然病史进行了系统回顾和荟萃分析:方法:以 "无症状"、"主动脉 "和 "狭窄 "为关键词,对 PubMed、Cochrane 和 Embase 数据库进行了检索,检索期从开始到 2024 年 1 月 24 日。我们纳入了对无症状重度 AS 患者的研究。在介入性试验中,只收集了保守治疗组的数据。利用从已发表的 Kaplan-Meier 曲线中重建的单个患者数据进行了单阶段荟萃分析。对随访期间一直无症状的患者的主要心血管不良结局进行了敏感性分析:共纳入 46 项研究(n = 9545)。出现症状的中位时间为 1.11 年(95% CI 0.90-1.53)。49.36%(40.85-58.59)的无症状患者在5年后发生了重大不良心血管事件。心力衰竭住院治疗(HFH)的无事件时间中位数为 5.50 年(95% CI 5.14-5.91),36.34%(95% CI 33.34-39.41)的患者在第 5 年时发生过 HFH。5年后,79.81%(95% CI 69.26-88.58)的患者出现症状(心绞痛、呼吸困难、晕厥等),12.36%(95% CI 10.01-15.22)的患者死于心血管疾病。全因死亡率的中位生存时间为 9.15 年(95% CI 8.50-9.96),39.43%(CI 33.41-36.40)的患者在 5 年内死亡。中位房室重建时间为 4.77 年(95% CI 4.39-5.17),52.64%(95% CI 49.85-55.48)的患者在 5 年前需要进行房室重建:我们的研究结果表明,接受保守治疗的无症状重度强直性脊柱炎患者的心血管预后较差。很大一部分患者最终需要进行房室重建。还需要进一步研究,以确定早期进行房室重建是否比保守治疗更有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Natural history of initially asymptomatic severe aortic stenosis: a one-stage meta-analysis.

Natural history of initially asymptomatic severe aortic stenosis: a one-stage meta-analysis.

Background: Current guidelines on the management strategy for patients with asymptomatic severe aortic stenosis (AS) remain unclear. This uncertainty stems from the lack of data regarding the natural history of these patients. To address this gap, we performed a systematic review and meta-analysis examining the natural history of asymptomatic severe AS patients receiving conservative treatment.

Methods: The PubMed, Cochrane, and Embase databases were searched from inception to 24 January 2024 using the keywords "asymptomatic" AND "aortic" AND "stenosis". We included studies examining patients with asymptomatic severe AS. In interventional trials, only data from conservatively managed arms were collected. A one-stage meta-analysis was conducted using individual patient data reconstructed from published Kaplan-Meier curves. Sensitivity analysis was performed for major adverse cardiovascular outcomes in patients who remained asymptomatic throughout follow-up.

Results: A total of 46 studies were included (n = 9545). The median time to the development of symptoms was 1.11 years (95% CI 0.90-1.53). 49.36% (40.85-58.59) of patients who were asymptomatic had suffered a major adverse cardiovascular event by 5 years. The median event-free time for heart failure hospitalization (HFH) was 5.50 years (95% CI 5.14-5.91) with 36.34% (95% CI 33.34-39.41) of patients experiencing an HFH by year 5. By 5 years, 79.81% (95% CI 69.26-88.58) of patients developed symptoms (angina, dyspnoea, syncope and others) and 12.36% (95% CI 10.01-15.22) of patients died of cardiovascular causes. For all-cause mortality, the median survival time was 9.15 years (95% CI 8.50-9.96) with 39.43% (CI 33.41-36.40) of patients dying by 5 years. The median time to AVR was 4.77 years (95% CI 4.39-5.17), with 52.64% (95% CI 49.85-55.48) of patients requiring an AVR by 5 years.

Conclusion: Our results reveal poor cardiovascular outcomes for patients with asymptomatic severe AS on conservative treatment. A significant proportion eventually requires an AVR. Further research is needed to determine if early intervention with AVR is more effective than conservative treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Research in Cardiology
Clinical Research in Cardiology 医学-心血管系统
CiteScore
11.40
自引率
4.00%
发文量
140
审稿时长
4-8 weeks
期刊介绍: Clinical Research in Cardiology is an international journal for clinical cardiovascular research. It provides a forum for original and review articles as well as critical perspective articles. Articles are only accepted if they meet stringent scientific standards and have undergone peer review. The journal regularly receives articles from the field of clinical cardiology, angiology, as well as heart and vascular surgery. As the official journal of the German Cardiac Society, it gives a current and competent survey on the diagnosis and therapy of heart and vascular diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信